Literature DB >> 4192097

Myopathy and malignant hyperpyrexia.

M A Denborough, P Ebeling, J O King, P Zapf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4192097     DOI: 10.1016/s0140-6736(70)91215-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  27 in total

1.  [Death from malignant hyperthermia during anaesthesia (author's transl)].

Authors:  I Bayer-Kristensen; E Reske-Nielsen; A Harmsen
Journal:  Z Rechtsmed       Date:  1975-11-11

2.  Malignant hyperthermia and althesin.

Authors:  N Honda; K Konno; Y Itohda; M Nishino; S Matsushima; S Haseba; Y Honda; Y Gotoh
Journal:  Can Anaesth Soc J       Date:  1977-07

Review 3.  Uses and limitations of enzyme tests.

Authors:  S B Rosalki
Journal:  Proc R Soc Med       Date:  1974-06

4.  Histochemical abnormalities of muscle in malignant hyperpyrexia (MH).

Authors:  H H Schiller
Journal:  Z Neurol       Date:  1973-02-26

Review 5.  Idiopathic rhabdomyolysis.

Authors:  D C Savage; M Forbes; G W Pearce
Journal:  Arch Dis Child       Date:  1971-10       Impact factor: 3.791

6.  Central-core disease and malignant hyperpyrexia.

Authors:  M A Denborough; X Dennett; R M Anderson
Journal:  Br Med J       Date:  1973-02-03

7.  Biochemical studies on malignant hyperpyrexia.

Authors:  R J Pennington; M Worsfold
Journal:  Proc R Soc Med       Date:  1973-01

8.  Identification of susceptibility to malignant hyperpyrexia.

Authors:  R F Moulds; M A Denborough
Journal:  Br Med J       Date:  1974-05-04

9.  Malignant hyperthermia: an investigation of five patients.

Authors:  B A Britt; W Kalow; A Gordon; J G Humphrey; N B Rewcastle
Journal:  Can Anaesth Soc J       Date:  1973-07

10.  Malignant hyperthermia: a disease of specific myofiber type?

Authors:  T E Nelson; S S Schochet
Journal:  Can Anaesth Soc J       Date:  1982-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.